2型糖尿病患者非酒精性脂肪性肝病的肝脏脂肪含量和肝纤维化严重程度与心外膜脂肪体积相关:一项前瞻性研究
该单中心前瞻性横断面研究纳入100例无已知冠心病的连续糖尿病患者,其中95例完成心脏CT、MR成像质子密度脂肪分数(PDFF)和MR弹性成像(MRE)检查。结果显示,以MR-PDFF≥5%定义的NAFLD组心外膜脂肪(EAT)体积高于非NAFLD组(126.5 ml vs 85.4 ml,p=0.002),MR-PDFF与EAT相关(r=0.42,p<0.0001),且MR-PDFF和肝纤维化是EAT的独立相关因素。作者认为较高的肝脏脂肪含量和肝纤维化可能预示糖尿病患者心血管风险更差。
要点
- 糖尿病患者中,MR-PDFF≥5%定义的NAFLD组EAT体积高于非NAFLD组(126.5 ml vs 85.4 ml,p=0.002)。
- 肝脏脂肪含量(MR-PDFF)与EAT体积呈正相关(r=0.42,p<0.0001)。
- MR-PDFF和肝纤维化与EAT独立相关,提示肝脏脂肪和纤维化可能影响心血管风险。
核心结论
- 较高的肝脏脂肪含量和肝纤维化可能预示糖尿病患者心血管风险更差。
研究设计与样本
- 单中心、前瞻性、横断面研究,2013年3月至2014年9月连续纳入100例无已知冠心病的糖尿病患者,其中95例完成心脏CT、MR成像质子密度脂肪分数(PDFF)和MR弹性成像(MRE)检查。
关键影像表现/征象
- NAFLD组(MR-PDFF≥5%)EAT体积为126.5 ml(IQR 80.9),非NAFLD组为85.4 ml(IQR 44.7),组间差异p=0.002。
诊断标准与关键数值
- NAFLD定义为MR成像质子密度脂肪分数(PDFF)≥5%。
- MR-PDFF与EAT体积相关(r=0.42,p<0.0001)。
- MR-PDFF和肝纤维化是EAT体积的独立相关因素。
临床应用与阅片要点
- 在糖尿病患者中,可关注MR-PDFF评估的肝脏脂肪含量及MRE评估的肝纤维化,这些指标与EAT体积独立相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether severity of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis quantitatively assessed in individuals with diabetes mellitus (DM)-2 correlate with increased coronary heart disease (CHD) risk using non-invasive markers.
METHODS: We conducted a single-centre, prospective, cross-sectional study in 100 consecutive diabetic individuals without known CHD recruited between March 2013 and September 2014. History, physical examination, serum markers, cardiac computed tomography (CT), magnetic resonance (MR) imaging-estimated proton density fat fraction (PDFF) and MR elastography (MRE) were obtained for 95 participants. Written informed consent was provided. Institutional review board approved this study. Spearman rank correlation was performed to assess for correlations. Multiple linear regression model determined independent predictors of epicardial adipose tissue (EAT) volume.
RESULTS: A p value < 0.05 determined statistical significance. The EAT volume was higher in the NAFLD group, defined as MR-imaging PDFF ≥ 5 %, compared to the non-NAFLD group (126.5 ml (IQR 80.9) versus 85.4 ml (IQR 44.7), p=0.002). MR imaging-PDFF correlated with EAT (r=0.42, p < 0.0001). MR imaging-PDFF and liver fibrosis were independently associated with EAT.
CONCLUSIONS: Higher liver fat content and liver fibrosis may portend worse cardiovascular risk in diabetics.
KEY POINTS: • EAT volume is higher in diabetic individuals with NAFLD. • Liver fat content is positively correlated with EAT. • Liver fat content and liver fibrosis were independently associated with EAT. • Higher liver fat content and fibrosis may adversely affect cardiovascular risk.
引用
- Brouha SS, Nguyen P, Bettencourt R, et al. Increased severity of liver fat content and liver fibrosis in non-alcoholic fatty liver disease correlate with epicardial fat volume in type 2 diabetes: A prospective study. Eur Radiol. 2017. PMID: 29058029. doi:10.1007/s00330-017-5075-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。